Skip to main content
Erschienen in: Inflammation 2/2013

01.04.2013

An Extragranular Compartment of Blood Eosinophils Contains Eosinophil Protein X/Eosinophil-Derived Neurotoxin (EPX/EDN)

verfasst von: Malgorzata Karawajczyk, Christer G. B. Peterson, Per Venge, Rodolfo C. Garcia

Erschienen in: Inflammation | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Serum and plasma profiles of eosinophil protein X (EPX/EDN) and those of other eosinophil proteins differ in various conditions, suggesting a different mobilisation from storage granules. This work studied the subcellular localisation of EPX/EDN in non-primed and in vivo primed blood eosinophils from healthy and allergic subjects, during and out of the pollen season. Primed eosinophils contain easily mobilisable secretory proteins. By fractionation on sucrose density gradients, EPX/EDN localised in the specific granules as well as in a cytoplasmic extra-granular compartment of low equilibrium density that partially overlapped with vesicular structures, cytosolic proteins and plasma membranes. This compartment was clearly separate from the low density peak of ECP that increases during the pollen season. There were no significant differences in the amounts of EPX/EDN present in the low density peak of healthy and allergic subjects. Immuno-gold labelling electron microscopy showed EPX/EDN in specific granules, cytoplasm and associated to plasma membranes. In conclusion, substantial amounts of EPX/EDN localise in an extra-granular, low equilibrium density compartment of human eosinophils.
Literatur
1.
Zurück zum Zitat Rothenberg, M.E., and S.P. Hogan. 2006. The eosinophil. Annual Review of Immunology 24: 147–174.PubMedCrossRef Rothenberg, M.E., and S.P. Hogan. 2006. The eosinophil. Annual Review of Immunology 24: 147–174.PubMedCrossRef
2.
Zurück zum Zitat Adamko, D.J., S.O. Odemuyiwa, D. Vethanayagam, and R. Moqbel. 2005. The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy 60: 13–22.PubMedCrossRef Adamko, D.J., S.O. Odemuyiwa, D. Vethanayagam, and R. Moqbel. 2005. The rise of the phoenix: the expanding role of the eosinophil in health and disease. Allergy 60: 13–22.PubMedCrossRef
3.
Zurück zum Zitat Hogan, S.P., H.F. Rosenberg, R. Moqbel, S. Phipps, P.S. Foster, P. Lacy, A.B. Kay, and M.E. Rothenberg. 2008. Eosinophils: biological properties and role in health and disease. Clinical and Experimental Allergy 38: 709–750.PubMedCrossRef Hogan, S.P., H.F. Rosenberg, R. Moqbel, S. Phipps, P.S. Foster, P. Lacy, A.B. Kay, and M.E. Rothenberg. 2008. Eosinophils: biological properties and role in health and disease. Clinical and Experimental Allergy 38: 709–750.PubMedCrossRef
4.
Zurück zum Zitat Peterson, C.G.B., and P. Venge. 1983. Purification and characterization of a new cationic protein - eosinophil protein X (EPX) - from granules of human eosinophils. Immunology 50: 19–26.PubMed Peterson, C.G.B., and P. Venge. 1983. Purification and characterization of a new cationic protein - eosinophil protein X (EPX) - from granules of human eosinophils. Immunology 50: 19–26.PubMed
5.
Zurück zum Zitat Slifman, N.R., P. Venge, C.G. Peterson, D.J. McKean, and G.J. Gleich. 1989. Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein. Journal of Immunology 143: 2317–2322. Slifman, N.R., P. Venge, C.G. Peterson, D.J. McKean, and G.J. Gleich. 1989. Human eosinophil-derived neurotoxin and eosinophil protein X are likely the same protein. Journal of Immunology 143: 2317–2322.
6.
Zurück zum Zitat Gullberg, U., B. Widegren, U. Arnason, A. Egesten, and I. Olsson. 1986. The cytotoxic eosinophil cationic protein (ECP) has ribunoclease activity. Biochemical and Biophysical Research Communications 139: 1239–1242.PubMedCrossRef Gullberg, U., B. Widegren, U. Arnason, A. Egesten, and I. Olsson. 1986. The cytotoxic eosinophil cationic protein (ECP) has ribunoclease activity. Biochemical and Biophysical Research Communications 139: 1239–1242.PubMedCrossRef
7.
Zurück zum Zitat Hamann, K.J., R.L. Barker, D.A. Loegering, L.R. Pease, and G.J. Gleich. 1989. Sequence of human eosinophil-derived neurotoxin cDNA: Identity of deduced amino acid sequence with human nonsecretory ribonucleases. Gene 83: 161–167.PubMedCrossRef Hamann, K.J., R.L. Barker, D.A. Loegering, L.R. Pease, and G.J. Gleich. 1989. Sequence of human eosinophil-derived neurotoxin cDNA: Identity of deduced amino acid sequence with human nonsecretory ribonucleases. Gene 83: 161–167.PubMedCrossRef
8.
Zurück zum Zitat Durack, D.T., S.J. Ackerman, D.A. Loegering, and G.J. Gleich. 1981. Purification of human eosinophil-derived neurotoxin. Proceedings of the National Academy of Sciences USA 78: 5165–5169.CrossRef Durack, D.T., S.J. Ackerman, D.A. Loegering, and G.J. Gleich. 1981. Purification of human eosinophil-derived neurotoxin. Proceedings of the National Academy of Sciences USA 78: 5165–5169.CrossRef
9.
Zurück zum Zitat Rosenberg, H.F., and J.B. Domachowske. 2001. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. Journal of Leukocyte Biology 70: 691–698.PubMed Rosenberg, H.F., and J.B. Domachowske. 2001. Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. Journal of Leukocyte Biology 70: 691–698.PubMed
10.
Zurück zum Zitat Yang, D., H.F. Rosenberg, Q. Chen, K.D. Dyer, K. Kurosaka, and J.J. Oppenheim. 2003. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 102: 3396–3403.PubMedCrossRef Yang, D., H.F. Rosenberg, Q. Chen, K.D. Dyer, K. Kurosaka, and J.J. Oppenheim. 2003. Eosinophil-derived neurotoxin (EDN), an antimicrobial protein with chemotactic activities for dendritic cells. Blood 102: 3396–3403.PubMedCrossRef
11.
Zurück zum Zitat Yang, D., Q. Chen, H.F. Rosenberg, S.M. Rybak, D.L. Newton, Z.Y. Wang, Q. Fu, V.T. Tchernev, M. Wang, B. Schweitzer, S.F. Kingsmore, D.D. Patel, J.J. Oppenheim, and O.M. Howard. 2004. Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. Journal of Immunology 173: 6134–6142. Yang, D., Q. Chen, H.F. Rosenberg, S.M. Rybak, D.L. Newton, Z.Y. Wang, Q. Fu, V.T. Tchernev, M. Wang, B. Schweitzer, S.F. Kingsmore, D.D. Patel, J.J. Oppenheim, and O.M. Howard. 2004. Human ribonuclease A superfamily members, eosinophil-derived neurotoxin and pancreatic ribonuclease, induce dendritic cell maturation and activation. Journal of Immunology 173: 6134–6142.
12.
Zurück zum Zitat Yang, D., Q. Chen, S.B. Su, P. Zhang, K. Kurosaka, R.R. Caspi, S.M. Michalek, H.F. Rosenberg, N. Zhang, and J.J. Oppenheim. 2008. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. The Journal of Experimental Medicine 205: 79–90.PubMedCrossRef Yang, D., Q. Chen, S.B. Su, P. Zhang, K. Kurosaka, R.R. Caspi, S.M. Michalek, H.F. Rosenberg, N. Zhang, and J.J. Oppenheim. 2008. Eosinophil-derived neurotoxin acts as an alarmin to activate the TLR2-MyD88 signal pathway in dendritic cells and enhances Th2 immune responses. The Journal of Experimental Medicine 205: 79–90.PubMedCrossRef
13.
Zurück zum Zitat Rosenberg, H.F., S.J. Ackerman, and D.G. Tenen. 1989. Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. Journal of Experimental Medicine 170: 163–176.PubMedCrossRef Rosenberg, H.F., S.J. Ackerman, and D.G. Tenen. 1989. Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity. Journal of Experimental Medicine 170: 163–176.PubMedCrossRef
14.
Zurück zum Zitat Peters, M.S., M. Rodriguez, and G.J. Gleich. 1986. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Laboratory Investigation 54: 656–662.PubMed Peters, M.S., M. Rodriguez, and G.J. Gleich. 1986. Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Laboratory Investigation 54: 656–662.PubMed
15.
Zurück zum Zitat Peterson, C.G.B., R.C. Garcia, M.G.Ch. Carlson, and P. Venge. 1987. Eosinophil cationic protein (ECP), eosinophil protein x (EPX) and eosinophil peroxidase (EPO): Granule distribution, degranulation and characterization of released proteins. In: Peterson, C.G.B. (Ed.), Eosinophil granule proteins: Biochemical and functional studies. Doctoral Thesis, Uppsala University, Uppsala, pp. 1–19. Peterson, C.G.B., R.C. Garcia, M.G.Ch. Carlson, and P. Venge. 1987. Eosinophil cationic protein (ECP), eosinophil protein x (EPX) and eosinophil peroxidase (EPO): Granule distribution, degranulation and characterization of released proteins. In: Peterson, C.G.B. (Ed.), Eosinophil granule proteins: Biochemical and functional studies. Doctoral Thesis, Uppsala University, Uppsala, pp. 1–19.
16.
Zurück zum Zitat Venge, P., R. Dahl, and C.G.B. Peterson. 1988. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication. International Archives of Allergy and Immunology 87: 306–312.CrossRef Venge, P., R. Dahl, and C.G.B. Peterson. 1988. Eosinophil granule proteins in serum after allergen challenge of asthmatic patients and the effects of anti-asthmatic medication. International Archives of Allergy and Immunology 87: 306–312.CrossRef
17.
Zurück zum Zitat Gore, C., C.G.B. Peterson, P. Kissen, B.M. Simpson, L.A. Lowe, A. Woodcock, and A. Custovic. 2003. Urinary eosinophilic protein X, atopy, and symptoms suggestive of allergic disease at 3 years of age. The Journal of Allergy and Clinical Immunology 112: 702–708.PubMedCrossRef Gore, C., C.G.B. Peterson, P. Kissen, B.M. Simpson, L.A. Lowe, A. Woodcock, and A. Custovic. 2003. Urinary eosinophilic protein X, atopy, and symptoms suggestive of allergic disease at 3 years of age. The Journal of Allergy and Clinical Immunology 112: 702–708.PubMedCrossRef
18.
Zurück zum Zitat Ott, N.L., G.J. Gleich, E.A. Peterson, T. Fujisawa, S. Sur, and K.M. Leiferman. 1994. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. The Journal of Allergy and Clinical Immunology 94: 120–128.PubMedCrossRef Ott, N.L., G.J. Gleich, E.A. Peterson, T. Fujisawa, S. Sur, and K.M. Leiferman. 1994. Assessment of eosinophil and neutrophil participation in atopic dermatitis: comparison with the IgE-mediated late-phase reaction. The Journal of Allergy and Clinical Immunology 94: 120–128.PubMedCrossRef
19.
Zurück zum Zitat Breuer, K., A. Kapp, and T. Werfel. 2001. Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age. Allergy 56: 780–784.PubMedCrossRef Breuer, K., A. Kapp, and T. Werfel. 2001. Urine eosinophil protein X (EPX) is an in vitro parameter of inflammation in atopic dermatitis of the adult age. Allergy 56: 780–784.PubMedCrossRef
20.
Zurück zum Zitat Carlson, M., Y. Raab, C. Peterson, R. Hallgren, and P. Venge. 1999. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. American Journal of Gastroenterology 94: 1876–1883.PubMedCrossRef Carlson, M., Y. Raab, C. Peterson, R. Hallgren, and P. Venge. 1999. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion. American Journal of Gastroenterology 94: 1876–1883.PubMedCrossRef
21.
Zurück zum Zitat Tischendorf, F.W., N.W. Brattig, G.D. Burchard, T. Kubica, G. Kreuzpaintner, and M. Lintzel. 1999. Eosinophils, eosinophil cationic protein and eosinophil-derived neurotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis. Acta Tropica 72: 157–173.PubMedCrossRef Tischendorf, F.W., N.W. Brattig, G.D. Burchard, T. Kubica, G. Kreuzpaintner, and M. Lintzel. 1999. Eosinophils, eosinophil cationic protein and eosinophil-derived neurotoxin in serum and urine of patients with onchocerciasis coinfected with intestinal nematodes and in urinary schistosomiasis. Acta Tropica 72: 157–173.PubMedCrossRef
22.
Zurück zum Zitat Tischendorf, F.W., N.W. Brattig, M. Lintzel, D.W. Buttner, G.D. Burchard, K. Bork, and M. Muller. 2000. Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis. Tropical Medicine & International Health 5: 898–905.CrossRef Tischendorf, F.W., N.W. Brattig, M. Lintzel, D.W. Buttner, G.D. Burchard, K. Bork, and M. Muller. 2000. Eosinophil granule proteins in serum and urine of patients with helminth infections and atopic dermatitis. Tropical Medicine & International Health 5: 898–905.CrossRef
23.
Zurück zum Zitat Koller, D.Y., M. Nilsson, I. Enander, P. Venge, and I. Eichler. 1998. Serum eosinophil cationic protein, eosinophil protein x and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis. Clinical and Experimental Allergy 28: 241–248.PubMedCrossRef Koller, D.Y., M. Nilsson, I. Enander, P. Venge, and I. Eichler. 1998. Serum eosinophil cationic protein, eosinophil protein x and eosinophil peroxidase in relation to pulmonary function in cystic fibrosis. Clinical and Experimental Allergy 28: 241–248.PubMedCrossRef
24.
Zurück zum Zitat Carlson, M., L. Håkansson, M. Kämpe, G. Stålenheim, C. Peterson, and P. Venge. 1992. Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. The Journal of Allergy and Clinical Immunology 89: 131–139.PubMedCrossRef Carlson, M., L. Håkansson, M. Kämpe, G. Stålenheim, C. Peterson, and P. Venge. 1992. Degranulation of eosinophils from pollen-atopic patients with asthma is increased during pollen season. The Journal of Allergy and Clinical Immunology 89: 131–139.PubMedCrossRef
25.
Zurück zum Zitat Seton, K., L. Håkansson, M. Karawajczyk, and P. Venge. 2003. The stimulus-dependent release of eosinophil cationic protein and eosinophil protein x increases in apoptotic eosinophils. Scandinavian Journal of Immunology 58: 312–320.PubMedCrossRef Seton, K., L. Håkansson, M. Karawajczyk, and P. Venge. 2003. The stimulus-dependent release of eosinophil cationic protein and eosinophil protein x increases in apoptotic eosinophils. Scandinavian Journal of Immunology 58: 312–320.PubMedCrossRef
26.
Zurück zum Zitat Melo, R.C.N., A.M. Dvorak, and P.F. Weller. 2010. Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils. Microscopy and Microanalysis 16: 653–660.PubMedCrossRef Melo, R.C.N., A.M. Dvorak, and P.F. Weller. 2010. Contributions of electron microscopy to understand secretion of immune mediators by human eosinophils. Microscopy and Microanalysis 16: 653–660.PubMedCrossRef
27.
Zurück zum Zitat Melo, R.C., L.A. Spencer, S.A. Perez, J.S. Neves, S. Bafford, E.S. Morgan, A.M. Dvorak, and P.F. Weller. 2009. Vesicle-mediated secretion of human eosinophil granule-derived major basic protein (MBP). Laboratory Investigation 89: 769–781.PubMedCrossRef Melo, R.C., L.A. Spencer, S.A. Perez, J.S. Neves, S. Bafford, E.S. Morgan, A.M. Dvorak, and P.F. Weller. 2009. Vesicle-mediated secretion of human eosinophil granule-derived major basic protein (MBP). Laboratory Investigation 89: 769–781.PubMedCrossRef
28.
Zurück zum Zitat Karawajczyk, M., L. Seveus, R. Garcia, E. Bjornsson, C.G. Peterson, G.M. Roomans, and P. Venge. 2000. Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season. American Journal of Respiratory Cell and Molecular Biology 23: 521–529.PubMed Karawajczyk, M., L. Seveus, R. Garcia, E. Bjornsson, C.G. Peterson, G.M. Roomans, and P. Venge. 2000. Piecemeal degranulation of peripheral blood eosinophils: a study of allergic subjects during and out of the pollen season. American Journal of Respiratory Cell and Molecular Biology 23: 521–529.PubMed
29.
Zurück zum Zitat Melo, R.C.N., L.A. Spencer, A.M. Dvorak, and P.F. Weller. 2008. Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. Journal of Leukocyte Biology 83: 229–236.PubMedCrossRef Melo, R.C.N., L.A. Spencer, A.M. Dvorak, and P.F. Weller. 2008. Mechanisms of eosinophil secretion: large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. Journal of Leukocyte Biology 83: 229–236.PubMedCrossRef
30.
Zurück zum Zitat Melo, R.C., and P.F. Weller. 2010. Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses. Histology and Histopathology 25: 1341–1354.PubMed Melo, R.C., and P.F. Weller. 2010. Piecemeal degranulation in human eosinophils: a distinct secretion mechanism underlying inflammatory responses. Histology and Histopathology 25: 1341–1354.PubMed
31.
Zurück zum Zitat Hansel, T.T., I.J.M. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. Journal of Immunological Methods 145: 105–110.PubMedCrossRef Hansel, T.T., I.J.M. De Vries, T. Iff, S. Rihs, M. Wandzilak, S. Betz, K. Blaser, and C. Walker. 1991. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. Journal of Immunological Methods 145: 105–110.PubMedCrossRef
32.
Zurück zum Zitat Storrie, B., and E.A. Madden. 1990. Isolation of subcellular organelles. Methods in Enzymology 182: 203–225.PubMedCrossRef Storrie, B., and E.A. Madden. 1990. Isolation of subcellular organelles. Methods in Enzymology 182: 203–225.PubMedCrossRef
33.
Zurück zum Zitat Calafat, J., T.W. Kuijpers, H. Janssen, N. Borregaard, A.J. Verhoeven, and D. Roos. 1993. Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CD11b/CD18. Blood 81: 3122–3129.PubMed Calafat, J., T.W. Kuijpers, H. Janssen, N. Borregaard, A.J. Verhoeven, and D. Roos. 1993. Evidence for small intracellular vesicles in human blood phagocytes containing cytochrome b558 and the adhesion molecule CD11b/CD18. Blood 81: 3122–3129.PubMed
34.
Zurück zum Zitat Peterson, C.G., I. Enander, J. Nystrand, A.S. Anderson, L. Nilsson, and P. Venge. 1991. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clinical and Experimental Allergy 21: 561–567.PubMedCrossRef Peterson, C.G., I. Enander, J. Nystrand, A.S. Anderson, L. Nilsson, and P. Venge. 1991. Radioimmunoassay of human eosinophil cationic protein (ECP) by an improved method. Establishment of normal levels in serum and turnover in vivo. Clinical and Experimental Allergy 21: 561–567.PubMedCrossRef
35.
Zurück zum Zitat Gartner, I. 1980. Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (Percoll). Immunology 40: 133–136.PubMed Gartner, I. 1980. Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (Percoll). Immunology 40: 133–136.PubMed
36.
Zurück zum Zitat Krouwels, F.H., L.C.M. Kerstens, H.W.M. Van der Maarel, H.J. Degenhart, and H.J. Neijens. 1995. Density of eosinophils reflects activity of disease in allergic asthmatic children. Clinical and Experimental Allergy 25: 1171–1178.PubMedCrossRef Krouwels, F.H., L.C.M. Kerstens, H.W.M. Van der Maarel, H.J. Degenhart, and H.J. Neijens. 1995. Density of eosinophils reflects activity of disease in allergic asthmatic children. Clinical and Experimental Allergy 25: 1171–1178.PubMedCrossRef
37.
Zurück zum Zitat Miyasato, M., S. Tsuda, T. Nakama, K. Kato, N. Kitamura, J. Nagaji, and Y. Sasai. 1996. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis. Journal of Dermatology 23: 382–388.PubMed Miyasato, M., S. Tsuda, T. Nakama, K. Kato, N. Kitamura, J. Nagaji, and Y. Sasai. 1996. Serum levels of eosinophil cationic protein reflect the state of in vitro degranulation of blood hypodense eosinophils in atopic dermatitis. Journal of Dermatology 23: 382–388.PubMed
38.
Zurück zum Zitat Hoffmann, H.J., T. Bjerke, M. Karawajczyk, R. Dahl, M.A. Knepper, and S. Nielsen. 2001. SNARE proteins are critical for regulated exocytosis of ECP from human eosinophils. Biochemical and Biophysical Research Communications 282: 194–199.PubMedCrossRef Hoffmann, H.J., T. Bjerke, M. Karawajczyk, R. Dahl, M.A. Knepper, and S. Nielsen. 2001. SNARE proteins are critical for regulated exocytosis of ECP from human eosinophils. Biochemical and Biophysical Research Communications 282: 194–199.PubMedCrossRef
39.
Zurück zum Zitat Bjerrum, O.W., and N. Borregaard. 1989. Dual granule localization of the dormant NADPH oxidase and cytochrome b559 in human neutrophils. European Journal of Haematology 43: 67–77.PubMedCrossRef Bjerrum, O.W., and N. Borregaard. 1989. Dual granule localization of the dormant NADPH oxidase and cytochrome b559 in human neutrophils. European Journal of Haematology 43: 67–77.PubMedCrossRef
40.
Zurück zum Zitat Metcalfe, D.D., J. Litvin, and S.I. Wasserman. 1982. The isolation, identification and characterization of sulfated glycosaminoglycans synthesized in vitro by human eosinophils. Biochimica et Biophysica Acta 715: 196–204.PubMedCrossRef Metcalfe, D.D., J. Litvin, and S.I. Wasserman. 1982. The isolation, identification and characterization of sulfated glycosaminoglycans synthesized in vitro by human eosinophils. Biochimica et Biophysica Acta 715: 196–204.PubMedCrossRef
41.
Zurück zum Zitat Rothenberg, M.E., J.L. Pomerantz, W.F. Owen, S. Avraham, R.J. Soberman, K.F. Austen, and R.L. Stevens. 1988. Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor. Journal of Biological Chemistry 263: 13901–13908.PubMed Rothenberg, M.E., J.L. Pomerantz, W.F. Owen, S. Avraham, R.J. Soberman, K.F. Austen, and R.L. Stevens. 1988. Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor. Journal of Biological Chemistry 263: 13901–13908.PubMed
42.
Zurück zum Zitat Zhang, H., X. Gao, C. Weng, and Z. Xu. 2008. Interaction between angiogenin and fibulin 1: evidence and implication. Acta Biochimica et Biophysica Sinica (Shanghai) 40: 375–380.CrossRef Zhang, H., X. Gao, C. Weng, and Z. Xu. 2008. Interaction between angiogenin and fibulin 1: evidence and implication. Acta Biochimica et Biophysica Sinica (Shanghai) 40: 375–380.CrossRef
43.
Zurück zum Zitat Melo, R.C., S.A. Perez, L.A. Spencer, A.M. Dvorak, and P.F. Weller. 2005. Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Traffic 6: 866–879.PubMedCrossRef Melo, R.C., S.A. Perez, L.A. Spencer, A.M. Dvorak, and P.F. Weller. 2005. Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Traffic 6: 866–879.PubMedCrossRef
44.
Zurück zum Zitat Melo, R.C., L.A. Spencer, S.A. Perez, I. Ghiran, A.M. Dvorak, and P.F. Weller. 2005. Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic 6: 1047–1057.PubMedCrossRef Melo, R.C., L.A. Spencer, S.A. Perez, I. Ghiran, A.M. Dvorak, and P.F. Weller. 2005. Human eosinophils secrete preformed, granule-stored interleukin-4 through distinct vesicular compartments. Traffic 6: 1047–1057.PubMedCrossRef
45.
Zurück zum Zitat Moqbel, R., and J.J. Coughlin. 2006. Differential secretion of cytokines. Sci. STKE 2006: pe26. Moqbel, R., and J.J. Coughlin. 2006. Differential secretion of cytokines. Sci. STKE 2006: pe26.
Metadaten
Titel
An Extragranular Compartment of Blood Eosinophils Contains Eosinophil Protein X/Eosinophil-Derived Neurotoxin (EPX/EDN)
verfasst von
Malgorzata Karawajczyk
Christer G. B. Peterson
Per Venge
Rodolfo C. Garcia
Publikationsdatum
01.04.2013
Verlag
Springer US
Erschienen in
Inflammation / Ausgabe 2/2013
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9549-z

Weitere Artikel der Ausgabe 2/2013

Inflammation 2/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.